News from us and our partners

Tags

Topics

0 results

News
26 January, 2017
Sofinnova Partners announces the acquisition of Delinia by Celgene Corporation
News
25 January, 2017
ObsEva SA Announces Pricing of Initial Public Offering
News
23 January, 2017
DNA Script adds Dr. Heiner Dreismann, former CEO of Roche Molecular Diagnostics, to Board of Directors
News
19 January, 2017
Cerenis - Clinical progress, cash position and revenue for Q4 2016
News
17 January, 2017
ObsEva Expands Leadership Team and Board of Directors with Industry Veterans
News
13 January, 2017
STENTYS- 2016 Annual Revenues up 20% at €7.3 Million
News
11 January, 2017
Pixium Vision réalise l’implantation de 10 patients avec IRIS® II, son système de vision bionique innovant à 150 électrodes, dans le cadre de son étude clinique
News
9 January, 2017
DNA Script to present at the Biotech Showcase conference in San Francisco
News
9 January, 2017
Corwave- Start-up & Co - BFM 04/01/2017
News
7 December, 2016
Lysogene Appoints David Schilansky to Board of Directors
News
6 December, 2016
Asceneuron appoints J. Michael Ryan, M.D. as Chief Medical Officer
News
24 November, 2016
Shockwave Medical Raises $45 Million in Series C Financing to Further Advance Novel Lithoplasty Treatment for Calcified Arteries
News
14 November, 2016
ProQR Announces Results for the Third Quarter of 2016
News
8 November, 2016
CorWave Raises $17.1 Million in Series B Financing
News
24 October, 2016
ObsEva Announces Results of the IMPLANT Phase 2 Trial of OBE001 (nolasiban) for the Improvement of Pregnancy and Live Birth Rates Following IVF/ICSI
News
11 October, 2016
Crescendo Biologics and Takeda Enter Collaboration for Humabody®-based Therapeutics Worth up to $790m

Sofinnova Partners announces the acquisition of Delinia by Celgene Corporation

ObsEva SA Announces Pricing of Initial Public Offering

DNA Script adds Dr. Heiner Dreismann, former CEO of Roche Molecular Diagnostics, to Board of Directors

Cerenis - Clinical progress, cash position and revenue for Q4 2016

ObsEva Expands Leadership Team and Board of Directors with Industry Veterans

STENTYS- 2016 Annual Revenues up 20% at €7.3 Million

Pixium Vision réalise l’implantation de 10 patients avec IRIS® II, son système de vision bionique innovant à 150 électrodes, dans le cadre de son étude clinique

DNA Script to present at the Biotech Showcase conference in San Francisco

Corwave- Start-up & Co - BFM 04/01/2017

Lysogene Appoints David Schilansky to Board of Directors

Asceneuron appoints J. Michael Ryan, M.D. as Chief Medical Officer

Shockwave Medical Raises $45 Million in Series C Financing to Further Advance Novel Lithoplasty Treatment for Calcified Arteries

ProQR Announces Results for the Third Quarter of 2016

CorWave Raises $17.1 Million in Series B Financing

ObsEva Announces Results of the IMPLANT Phase 2 Trial of OBE001 (nolasiban) for the Improvement of Pregnancy and Live Birth Rates Following IVF/ICSI

Crescendo Biologics and Takeda Enter Collaboration for Humabody®-based Therapeutics Worth up to $790m